AXSOME THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
AXSOME THERAPEUTICS, INC. (AXSM) reported Earnings Per Share, Basic and Diluted of -$1.03 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-02
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.03.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.90.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.93.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.86.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$3.47.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.77.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.01.
- AXSOME THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.15.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.03 10-Q · filed 2022-05-02 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.86 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.72 derived: net income ÷ weighted average shares · filed 2026-04-24 |
| 2021-12-31 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.68 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.47 10-K · filed 2022-03-01 |
| 2021-09-30 | -$0.93 10-Q · filed 2021-11-08 | -$1.78 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$2.57 10-Q · filed 2021-11-08 | -$3.35 derived: net income ÷ weighted average shares · filed 2022-11-07 |
| 2021-06-30 | -$0.86 10-Q · filed 2021-08-09 | -$1.64 10-Q · filed 2021-08-09 | -$2.42 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$3.04 derived: net income ÷ weighted average shares · filed 2022-11-07 |
| 2021-03-31 | -$0.78 10-Q · filed 2022-05-02 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$2.18 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$2.67 derived: net income ÷ weighted average shares · filed 2022-11-07 |
| 2020-12-31 | -$0.79 10-K · filed 2021-03-01 | -$1.40 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.89 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.77 10-K · filed 2022-03-01 |
| 2020-09-30 | -$0.61 10-Q · filed 2021-11-08 | -$1.11 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$1.98 10-Q · filed 2021-11-08 | -$2.70 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-06-30 | -$0.49 10-Q · filed 2021-08-09 | -$1.37 10-Q · filed 2021-08-09 | -$2.08 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.64 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-03-31 | -$0.88 10-Q · filed 2021-05-10 | -$1.60 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.16 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.58 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2019-12-31 | -$0.71 10-K · filed 2021-03-01 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.68 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.01 10-K · filed 2022-03-01 |
| 2019-09-30 | -$0.56 10-K · filed 2021-03-01 | -$0.96 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.29 10-Q · filed 2020-11-05 | -$1.62 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-06-30 | -$0.41 10-K · filed 2021-03-01 | -$0.73 10-Q · filed 2020-08-10 | -$1.05 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.37 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-03-31 | -$0.32 10-K · filed 2021-03-01 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.96 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.28 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2018-12-31 | -$0.32 10-K · filed 2020-03-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.96 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.15 10-K · filed 2021-03-01 |
| 2018-09-30 | -$0.31 10-K · filed 2020-03-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$0.83 10-Q · filed 2019-11-07 | -$1.13 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2018-06-30 | -$0.32 10-K · filed 2020-03-12 | -$0.51 10-Q · filed 2019-08-08 | -$0.81 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.09 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2018-03-31 | -$0.19 10-K · filed 2020-03-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.06 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2017-12-31 | -$0.31 10-K · filed 2019-03-15 | -$0.58 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$0.88 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.27 10-K · filed 2020-03-12 |
| 2017-09-30 | -$0.27 10-K · filed 2019-03-15 | -$0.57 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.97 10-Q · filed 2018-11-09 | -$1.34 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-06-30 | -$0.30 10-K · filed 2019-03-15 | -$0.70 10-Q · filed 2018-08-08 | -$1.08 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.45 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-03-31 | -$0.41 10-K · filed 2019-03-15 | -$0.79 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.17 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.52 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2016-12-31 | -$0.38 10-K · filed 2018-03-07 | -$0.76 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.11 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.42 10-K · filed 2019-03-15 |
| 2016-09-30 | -$0.38 10-K · filed 2018-03-07 | -$0.73 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.04 10-Q · filed 2017-11-08 | -$1.29 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2016-06-30 | -$0.36 10-K · filed 2018-03-07 | -$0.66 10-Q · filed 2017-08-09 | -$0.91 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.29 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2016-03-31 | -$0.31 10-K · filed 2018-03-07 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.93 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.14 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2015-12-31 | -$0.23 10-K · filed 2017-03-07 | -$0.62 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.82 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.02 10-K · filed 2018-03-07 |
| 2015-09-30 | -$0.41 10-K · filed 2017-03-07 | -$0.60 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.80 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$0.19 10-K · filed 2017-03-07 | -$0.38 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$0.19 10-K · filed 2017-03-07 | |||
| 2014-12-31 | -$0.66 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |